With box warnings

Without box warnings

Branded

Generic

3 results

nucala
(mepolizumab)
GlaxoSmithKline LLC
Usage: NUCALA is indicated for the add-on maintenance treatment of severe asthma (ages 6+), chronic rhinosinusitis with nasal polyps (ages 18+), inadequate chronic obstructive pulmonary disease (COPD), eosinophilic granulomatosis with polyangiitis in adults, and hypereosinophilic syndrome in patients aged 12 and older.
xhance
(fluticasone propionate)
OptiNose US, Inc.
Usage: XHANCE is indicated for the treatment of chronic rhinosinusitis in adults, both with nasal polyps (CRSwNP) and without nasal polyps (CRSsNP).
xolair
(omalizumab)
Genentech, Inc.
Usage: XOLAIR is indicated for adults and children aged 6 and older with moderate to severe asthma, chronic rhinosinusitis with nasal polyps, IgE-mediated food allergies, and chronic spontaneous urticaria. It is not for acute bronchospasm or emergency allergic reactions.

Medications for Chronic Rhinosinusitis With Multiple Nasal Polyps

nucala